A proposed animal model for hallucinogens based on LSD's effects on patterns of exploration in rats
Adams LM, Geyer MA A proposed animal model for hallucinogens based on LSD's effects on patterns of exploration in rats. Behav Neurosci. 99:1985;881-900.
Approaches to the characterization of drug effects on locomotor activity in rodents
M.W. Adler, & A. Cowan. New York: Wiley-Liss
Geyer MA Approaches to the characterization of drug effects on locomotor activity in rodents. Adler MW, Cowan A Modern Methods in Pharmacology. Testing and Evaluation of Drugs of Abuse:1990;81-99 Wiley-Liss, New York.
Serotonin receptor involvement in an animal model of the acute effects of hallucinogens
G. Lin, & R.A. Glennon. Rockvill, MD: National Institute on Drug Abuse
Geyer MA, Krebs KM Serotonin receptor involvement in an animal model of the acute effects of hallucinogens. Lin G, Glennon RA Hallucinogens. An Update:1994;124-156 National Institute on Drug Abuse, Rockvill, MD.
Dissociation of multiple effects of acute LSD on exploratory behavior in rats by ritanserin and propranolol
Mittman SM, Geyer MA Dissociation of multiple effects of acute LSD on exploratory behavior in rats by ritanserin and propranolol. Psychopharmacology. 105:1991;69-76.
2A antagonist MDL 100,907 on disruption of sound and light prepulse inhibition produced by 5-HT agonists in Wistar rats
2A antagonist MDL 100,907 on disruption of sound and light prepulse inhibition produced by 5-HT agonists in Wistar rats Psychopharmacology. 124:1996;107-116.
Blockade of the discriminative stimulus effects of DOI by MDL 100,907 and the "atypical" antipsychotics, clozapine and risperidone
Schreiber R, Brocco M, Millan MJ Blockade of the discriminative stimulus effects of DOI by MDL 100,907 and the "atypical" antipsychotics, clozapine and risperidone. Eur J Pharmacol. 264:1994;99-102.
Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens
Titeler M, Lyon RA, Glennon RA Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens. Psychopharmacology. 94:1988;213-216.